Trump administration cancels plans to develop a bird flu vaccine
a year ago
- #public health
- #vaccine development
- #H5N1
- Trump administration cancels $766 million contract with Moderna to develop an mRNA bird flu vaccine.
- Decision based on concerns about mRNA technology's safety and lack of sufficient testing.
- HHS shifts focus to vaccine platforms with better-established safety profiles and transparent data practices.
- Moderna reports positive interim results from Phase 1/2 study of H5 avian flu vaccine.
- Experts criticize the decision, warning it leaves the U.S. unprepared for potential pandemics.
- H5N1 virus has spread to multiple dairy herds and poultry farms, with limited human cases so far.